arrow
O

Oreste Villani

irccs centro di riferimento oncologico della basilicata
H指数:21
被引数:1,299

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs
2020-02-088
PREAI
Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

再次挑战仍然是多发性骨髓瘤的挽救治疗选择吗?现实生活中再次使用硼替佐米作为复发患者的第二次治疗的情况下,一线暴露于基于硼替佐米的疗法 (反弹研究)

2018-10-234
PREAI
EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells
2017-07-1816
PREAI
MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report

血清来源的细胞外囊泡作为血液系统恶性肿瘤的潜在生物标志物的MicroRNA-155-简短报告

2016-10-1975
PREAI
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma
LEUKEMIA
IF13.4
2016-02-2233
PREAI
Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party study
2015-04-1723
OAAI
Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia
LEUKEMIA
IF13.4
2013-08-2076
OA
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party

含有硼替佐米的联合一线化疗可提高原发性浆细胞白血病的缓解率和生存率: 来自GIMEMA多发性骨髓瘤工作组的回顾性研究

2012-06-0160
OAAI
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia
2012-03-2834
PREAI